PLX vs W · P/E 31, rev $53.4M vs rev $11.85B
Protalix Biotherapeutics Inc (PLX) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
PLX currently screens at market cap $122.6M and trailing P/E 30.8. W currently screens at market cap $10.77B.
Not investment advice. Open the PLX and W stock pages for the full models.
Not investment advice.